Legend Biotech to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Legend Biotech Corporation (NASDAQ: LEGN) has announced its participation in the Jefferies Virtual Healthcare Conference on June 3, 2021, at 9:30 am ET. Interested parties can access the webcast via the Legend Biotech website. This clinical-stage biopharmaceutical company focuses on developing novel cell therapies, particularly its lead candidate, cilta-cel, an investigational CAR-T therapy aimed at multiple myeloma patients. With over 800 employees globally, Legend Biotech is positioned to advance best-in-class cell therapies for oncology.

Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced it will present at the Jefferies Virtual Healthcare Conference on June 3, 2021 at 9:30 am ET. This webcast will be available to investors and other interested parties by accessing the Legend Biotech website at https://investors.legendbiotech.com

About Legend Biotech

Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Our team of over 800 employees across the United States, China and Europe, along with our differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture best-in-class cell therapies for patients in need.

We are engaged in a strategic collaboration to develop and commercialize our lead product candidate, cilta-cel, an investigational BCMA-targeted CAR-T cell therapy for patients living with multiple myeloma. This candidate is currently being studied in registrational clinical trials.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210525005582/en/

FAQ

What is the date and time of Legend Biotech's presentation at the Jefferies Virtual Healthcare Conference?

Legend Biotech will present at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 9:30 am ET.

Where can I access the webcast for Legend Biotech's conference presentation?

The webcast for Legend Biotech's presentation can be accessed on their official website at https://investors.legendbiotech.com.

What is cilta-cel, and what is its significance to Legend Biotech?

Cilta-cel is an investigational BCMA-targeted CAR-T cell therapy being developed by Legend Biotech for treating patients with multiple myeloma.

How many employees does Legend Biotech have globally?

Legend Biotech has over 800 employees across the United States, China, and Europe.

What type of therapies does Legend Biotech focus on developing?

Legend Biotech specializes in the discovery and development of novel cell therapies, particularly for oncology and related indications.